Growing community of inventors

Champaign, IL, United States of America

Sung Hoon Kim

Average Co-Inventor Count = 4.35

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Sung Hoon KimJohn A Katzenellenbogen (5 patents)Sung Hoon KimBenita Katzenellenbogen (4 patents)Sung Hoon KimSeema K Tiwari-Woodruff (2 patents)Sung Hoon KimPhilip Shaul (1 patent)Sung Hoon KimNoah Bindman (1 patent)Sung Hoon KimYounghoon Kim (1 patent)Sung Hoon KimMelikhan Tanyeri (1 patent)Sung Hoon KimZeynep Madak-Erdogan (1 patent)Sung Hoon KimCharles M Schroeder, Iii (1 patent)Sung Hoon KimSung Hoon Kim (5 patents)John A KatzenellenbogenJohn A Katzenellenbogen (10 patents)Benita KatzenellenbogenBenita Katzenellenbogen (4 patents)Seema K Tiwari-WoodruffSeema K Tiwari-Woodruff (2 patents)Philip ShaulPhilip Shaul (3 patents)Noah BindmanNoah Bindman (1 patent)Younghoon KimYounghoon Kim (1 patent)Melikhan TanyeriMelikhan Tanyeri (1 patent)Zeynep Madak-ErdoganZeynep Madak-Erdogan (1 patent)Charles M Schroeder, IiiCharles M Schroeder, Iii (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. University of Illinois (5 from 2,340 patents)

2. University of California (2 from 15,458 patents)

3. University of Texas System (1 from 5,444 patents)


5 patents:

1. 12286407 - Estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (MS) and other demyelinating, inflammatory and neurodegenerative diseases

2. 12187662 - FOXM1 inhibitor compositions and methods of using the same

3. 11673866 - Estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (MS) and other demyelinating, inflammatory and neurodegenerative diseases

4. 10703698 - Compounds which activate estrogen receptors and compositions and methods of using the same

5. 9448173 - Dye-conjugated dendrimers

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/7/2025
Loading…